drugset / Trial / NCT02494349

The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers.

NCT02494349

Phase 1 Completed 54 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate and compare the pharmacokinetic characteristics and safety/tolerability between JLP-1207(Solifenacin/Tamsulosin 5mg/0.2mg)and co-administration of Solifenacin and Tamsulosin between Solifenacin and Tamsulosin in healthy male volunteers.

Timeline

Start
2015-08
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject JLP-1207 Unknown
Subject Solifenacin Small molecule 5 mg
Subject Tamsulosin Other / unclassified 0.2 mg